Analysis of HER-3, insulin growth factor-1, nuclear factor-kB and epidermal growth factor receptor gene copy number in the prediction of clinical outcome for K-RAS wild-type colorectal cancer patients receiving irinotecan-cetuximab. (Q44284095)
Jump to navigation
Jump to search
scientific article published on 23 November 2011
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Analysis of HER-3, insulin growth factor-1, nuclear factor-kB and epidermal growth factor receptor gene copy number in the prediction of clinical outcome for K-RAS wild-type colorectal cancer patients receiving irinotecan-cetuximab. |
scientific article published on 23 November 2011 |
Statements
Analysis of HER-3, insulin growth factor-1, nuclear factor-kB and epidermal growth factor receptor gene copy number in the prediction of clinical outcome for K-RAS wild-type colorectal cancer patients receiving irinotecan-cetuximab (English)
R Giampieri
A Mandolesi
L Giustini
R Silva
A Zaniboni
T Biscotti
S Biagetti
E Galizia
23 November 2011